Glioblastoma (GBM), primary central nervous system lymphoma (PCNSL), and brain metastases (BM) are three common malignant central nervous system tumors. Accurate preoperative differentiation is essential for appropriate treatment planning and prognosis, however, it’s challenging to differentiate these tumors using MRI due to their similar anatomical structures and imaging characteristics. In this paper, we first construct a new multi-center brain MRI dataset, including 315 training cases (GBM 64, PCNSL 59, BM 192) and 124 external test cases (24:23:77). Moreover, we propose a novel framework FoTNet for accurate diagnosis of the three tumors. Our model achieves a classification accuracy of 92.5% and an average AUC of 0.9754, outperforming previous methods. Our results demonstrates the great potential of AI in assisting physicians in differentiating between GBM, PCNSL, and BM, particularly in resource-limited clinical settings.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

FoTNet Enables Preoperative Differentiation of Malignant Brain Tumors with Deep Learning

  • Chenyi Hong,
  • Hualiang Wang,
  • Zhuoxuan Wu,
  • Zuozhu Liu,
  • Junhui Lv

摘要

Glioblastoma (GBM), primary central nervous system lymphoma (PCNSL), and brain metastases (BM) are three common malignant central nervous system tumors. Accurate preoperative differentiation is essential for appropriate treatment planning and prognosis, however, it’s challenging to differentiate these tumors using MRI due to their similar anatomical structures and imaging characteristics. In this paper, we first construct a new multi-center brain MRI dataset, including 315 training cases (GBM 64, PCNSL 59, BM 192) and 124 external test cases (24:23:77). Moreover, we propose a novel framework FoTNet for accurate diagnosis of the three tumors. Our model achieves a classification accuracy of 92.5% and an average AUC of 0.9754, outperforming previous methods. Our results demonstrates the great potential of AI in assisting physicians in differentiating between GBM, PCNSL, and BM, particularly in resource-limited clinical settings.